These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23703881)

  • 1. Kidney stones: a fetal origins hypothesis.
    Howles SA; Edwards MH; Cooper C; Thakker RV
    J Bone Miner Res; 2013 Dec; 28(12):2535-9. PubMed ID: 23703881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis--2012 Curt Richter Award Winner.
    Reynolds RM
    Psychoneuroendocrinology; 2013 Jan; 38(1):1-11. PubMed ID: 22998948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Gestational Diabetes Mellitus and Future Risk of Kidney Stones.
    Mao Y; Hu W; Liu L; Liu Q
    Front Public Health; 2022; 10():843383. PubMed ID: 35237556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of Association of Metabolic Syndrome and Risk Factors of Nephrolithiasis.
    Karoli R; Fatima J; Karoli Y; Singh PS; Siddiqi Z; Shukla V; Khan FA
    J Assoc Physicians India; 2021 Jan; 69(1):32-35. PubMed ID: 34227773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and stone disease.
    Soligo M; Morlacco A; Zattoni F; Valotto C; DE Giorgi G; Beltrami P
    Panminerva Med; 2022 Sep; 64(3):344-358. PubMed ID: 34609121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between metabolic syndrome components and the risk of developing nephrolithiasis: A systematic review and bayesian meta-analysis.
    Rahman IA; Nusaly IF; Syahrir S; Nusaly H; Mansyur MA
    F1000Res; 2021; 10():104. PubMed ID: 34804491
    [No Abstract]   [Full Text] [Related]  

  • 7. KIDNEY STONE DISEASE WITH SPECIAL REGARD TO DRUG-INDUCED KIDNEY STONES - A CONTEMPORARY SYNOPSIS.
    Dobrek Ł
    Wiad Lek; 2020; 73(9 cz. 2):2031-2039. PubMed ID: 33148855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Syndrome and Kidney Stone Disease: A Systematic Review of Literature.
    Wong Y; Cook P; Roderick P; Somani BK
    J Endourol; 2016 Mar; 30(3):246-53. PubMed ID: 26576717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Different Biochemical and Hemodynamic Characteristic with Type 2 Diabetes Mellitus and Hypertension in Nephrolithiasis Patients.
    Katwal BM; Gautam N; Shrestha S; Adhikari R; Baral H; Jha SK; Jha G
    Kathmandu Univ Med J (KUMJ); 2023; 21(81):58-63. PubMed ID: 37800427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Syndrome Negatively Impacts Stone-Specific Quality of Life.
    Lim JRZ; Scotland KB; Bechis SK; Sur RL; Nakada SY; Antonelli JA; Streeper NM; Sivalingam S; Viprakasit DP; Averch TD; Landman J; Chi T; Pais VM; Bird VG; Andonian S; Bhojani N; Canvasser NE; Harper JD; Penniston KL; Chew BH
    J Endourol; 2020 Nov; 34(11):1203-1208. PubMed ID: 32689819
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of dysbiosis on kidney stones that risk up renal cell carcinoma (RCC).
    Gupta S; Singh Kanwar S
    Semin Cancer Biol; 2021 May; 70():134-138. PubMed ID: 32569823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of nephrolithiasis with hypertension and obesity: a review.
    Obligado SH; Goldfarb DS
    Am J Hypertens; 2008 Mar; 21(3):257-64. PubMed ID: 18219300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential arterial hypertension and stone disease.
    Borghi L; Meschi T; Guerra A; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of potential kidney donors with asymptomatic kidney stones.
    Lorenz EC; Lieske JC; Vrtiska TJ; Krambeck AE; Li X; Bergstralh EJ; Melton LJ; Rule AD
    Nephrol Dial Transplant; 2011 Aug; 26(8):2695-700. PubMed ID: 21285126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic and Hypertensive Complications of Pregnancy in Women with Nephrolithiasis.
    Tangren JS; Powe CE; Ecker J; Bramham K; Ankers E; Karumanchi SA; Thadhani R
    Clin J Am Soc Nephrol; 2018 Apr; 13(4):612-619. PubMed ID: 29472305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relationship Between Renal Stones and Primary Aldosteronism.
    Chang CK; Chang CC; Wu VC; Geng JH; Lee HY
    Front Endocrinol (Lausanne); 2022; 13():828839. PubMed ID: 35222284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and kidney stone disease: a systematic review.
    Carbone A; Al Salhi Y; Tasca A; Palleschi G; Fuschi A; De Nunzio C; Bozzini G; Mazzaferro S; Pastore AL
    Minerva Urol Nefrol; 2018 Aug; 70(4):393-400. PubMed ID: 29856171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission.
    Schernthaner-Reiter MH; Siess C; Gessl A; Scheuba C; Wolfsberger S; Riss P; Knosp E; Luger A; Vila G
    Endocrine; 2019 Apr; 64(1):157-168. PubMed ID: 30467627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietetic and lifestyle recommendations for stone formers.
    Ferraro PM; Bargagli M
    Arch Esp Urol; 2021 Jan; 74(1):112-122. PubMed ID: 33459627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.